OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

Retrovirology

Volumn 6, Issue SUPPL. 3, 2009, Pages

  Baden, L R ^a   Dolin, R ^b   O'Brien, K L ^c   Abbink, P ^c   La Porte, A ^c   Seaman, M S ^c   Choi, E ^a   Tucker, R ^a   Weitjens, M ^b   Pau, M G ^b   Goudsmit, J ^b   Barouch, D H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CRUCELL HOLLAND BV   (Netherlands)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449629857     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-S3-O36     Document Type: Note

References (0)